Literature DB >> 26436534

Quantification of Colonic Stem Cell Mutations.

Ryan D Whetstone1, Barry Gold2.   

Abstract

The ability to measure stem cell mutations is a powerful tool to quantify in a critical cell population if, and to what extent, a chemical can induce mutations that potentially lead to cancer. The use of an enzymatic assay to quantify stem cell mutations in the X-linked glucose-6-phosphate dehydrogenase gene has been previously reported.(1) This method requires the preparation of frozen sections and incubation of the sectioned tissue with a reaction mixture that yields a blue color if the cells produce functional glucose-6-phosphate dehydrogenase (G6PD) enzyme. If not, the cells appear whitish. We have modified the reaction mixture using Optimal Cutting Temperature Compound (OCT) medium in place of polyvinyl alcohol. This facilitates pH measurement, increases solubilization of the G6PD staining components and restricts diffusion of the G6PD enzyme. To demonstrate that a mutation occurred in a stem cell, the entire crypt must lack G6PD enzymatic activity. Only if a stem cell harbors a phenotypic G6PD mutation will all of the progeny in the crypt lack G6PD enzymatic activity. To identify crypts with a stem cell mutation, four consecutive adjacent frozen sections (a level) were cut at 7 µm thicknesses. This approach of making adjacent cuts provides conformation that a crypt was fully mutated since the same mutated crypt will be observed in adjacent sections. Slides with tissue samples that were more than 50 µm apart were prepared to assess a total of >10(4) crypts per mouse. The mutation frequency is the number of observed mutated (white) crypts÷by the number of wild type (blue) crypts in a treatment group.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26436534      PMCID: PMC4692627          DOI: 10.3791/53240

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  Differences in susceptibility to colonic stem cell somatic mutation in three strains of mice.

Authors:  M Kuraguchi; H Cook; E D Williams; G A Thomas
Journal:  J Pathol       Date:  2001-04       Impact factor: 7.996

2.  Crypt-restricted metallothionein immunopositivity in murine colon: validation of a model for studies of somatic stem cell mutation.

Authors:  H Anne Cook; D Williams; G Anne Thomas
Journal:  J Pathol       Date:  2000-07       Impact factor: 7.996

Review 3.  Polyvinyl alcohol and other tissue protectants in enzyme histochemistry: a consumer's guide.

Authors:  C J Van Noorden; I M Vogels
Journal:  Histochem J       Date:  1989-07

4.  Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane.

Authors:  R Suzuki; H Kohno; S Sugie; T Tanaka
Journal:  Histol Histopathol       Date:  2005-04       Impact factor: 2.303

5.  Somatic mutation of the glucose-6-phosphate dehydrogenase (g6pd) gene in colonic stem cells and crypt restricted loss of G6PD activity.

Authors:  M Kuraguchi; G A Thomas; E D Williams
Journal:  Mutat Res       Date:  1997-09-05       Impact factor: 2.433

6.  T-cells enhance stem cell mutagenesis in the mouse colon.

Authors:  Ryan D Whetstone; Barry Gold
Journal:  Mutat Res       Date:  2015-03-04       Impact factor: 2.433

7.  Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry.

Authors:  D F Griffiths; S J Davies; D Williams; G T Williams; E D Williams
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

8.  A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate.

Authors:  Takuji Tanaka; Hiroyuki Kohno; Rikako Suzuki; Yasuhiro Yamada; Shigeyuki Sugie; Hideki Mori
Journal:  Cancer Sci       Date:  2003-11       Impact factor: 6.716

Review 9.  Histochemistry and cytochemistry of glucose-6-phosphate dehydrogenase.

Authors:  C J Van Noorden
Journal:  Prog Histochem Cytochem       Date:  1984

10.  The clonal origin of experimental large bowel tumours.

Authors:  D F Griffiths; P Sacco; D Williams; G T Williams; E D Williams
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.